Insider Transactions in Q1 2022 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Paul Daruwala Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+17.4%
|
-
|
|
Mar 31
2022
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+20.16%
|
-
|
|
Mar 31
2022
|
Jeffrey Stein President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
140,985
-13.26%
|
$0
$0.83 P/Share
|
|
Mar 31
2022
|
Jeffrey Stein President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
573,742
+23.94%
|
-
|
|
Mar 31
2022
|
Shane Ward COO & CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,122
-22.23%
|
$0
$0.83 P/Share
|
|
Mar 31
2022
|
Shane Ward COO & CLO |
BUY
Grant, award, or other acquisition
|
Direct |
104,027
+44.94%
|
-
|
|
Mar 31
2022
|
Taylor Sandison Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+14.04%
|
-
|
|
Mar 31
2022
|
Preetam Shah Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,820
-18.08%
|
$0
$0.83 P/Share
|
|
Mar 31
2022
|
Preetam Shah Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,251
+37.15%
|
-
|
|
Mar 31
2022
|
Brady Johnson Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+14.42%
|
-
|
|
Mar 21
2022
|
Brady Johnson Vice President, Finance |
SELL
Open market or private sale
|
Direct |
654
-1.31%
|
$0
$0.81 P/Share
|
|
Mar 11
2022
|
Brady Johnson Vice President, Finance |
SELL
Open market or private sale
|
Direct |
945
-1.85%
|
$0
$0.71 P/Share
|
|
Jan 05
2022
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,252
-0.8%
|
$1,252
$1.25 P/Share
|
|
Jan 05
2022
|
Brady Johnson Vice President, Finance |
SELL
Open market or private sale
|
Direct |
416
-0.81%
|
$416
$1.25 P/Share
|
|
Jan 05
2022
|
Paul Daruwala Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,133
-2.67%
|
$5,133
$1.25 P/Share
|